Fabio Pammolli
#171,093
Most Influential Person Now
Italian economist
Fabio Pammolli's AcademicInfluence.com Rankings
Download Badge
Economics
Fabio Pammolli's Degrees
- PhD Economics University of Florence
Why Is Fabio Pammolli Influential?
(Suggest an Edit or Addition)According to Wikipedia, Fabio Pammolli is an Italian economist, who is professor of finance and data science at Politecnico di Milano, and former president of Constructor University in Bremen, Germany. Biography Pammolli graduated in economics at the University of Pisa and did his doctoral studies at the Sant’Anna School of Advanced Studies. In 1988-89 he served as an officer and as an instructor in Guardia di Finanza. From 1990 he served as an assistant and then as an associate professor at the University of Siena, while from 2001 he served as full professor at the University of Florence. Research stays have taken him to the Department of Physics at Boston University, where he collaborated with H.E. Stanley. He was then a visiting scientist at STICERD at the LSE, OFCE at Sciences Po, the Department of Economics, Harvard University and LIDS, at the Massachusetts Institute of Technology. From 2004 to 2013 he served as the founding rector of the IMT School for Advanced Studies in Lucca and worked there as a professor of economics, finance, and data science. In 2015 he served as a senior scientist at the Italian Institute of Technology, where he contributed to conceive and design the strategic plan of the Human Technopole.
Fabio Pammolli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- On the Size Distribution of Business Firms (2008) (2338)
- The productivity crisis in pharmaceutical R&D (2011) (824)
- Special Issue on University Entrepreneurship and Technology Transfer: A Comparison of U.S. and European University-Industry Relations in the Life Sciences (2002) (493)
- Evidence of economic segregation from mobility lockdown during COVID-19 epidemic (2020) (445)
- Technological change and network dynamics: Lessons from the pharmaceutical industry (2001) (385)
- Innovation and Corporate Growth in the Evolution of the Drug Industry (2001) (354)
- Economic and social consequences of human mobility restrictions under COVID-19 (2020) (335)
- Reputation and impact in academic careers (2013) (221)
- The growth of business firms: theoretical framework and empirical evidence. (2005) (183)
- Global Competitiveness in Pharmaceuticals: A European Perspective (2000) (160)
- Persistence and uncertainty in the academic career (2012) (139)
- A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development (2009) (130)
- Human mobility in response to COVID-19 in France, Italy and UK (2020) (102)
- The sustainability of European health care systems: beyond income and aging (2012) (100)
- Networks of innovators within and across borders. Evidence from patent data (2013) (94)
- Pharmaceuticals Analyzed through the Lens of a Sectoral Innovation System (2004) (92)
- Evolution of Controllability in Interbank Networks (2013) (89)
- The Evolution of Knowledge and the Dynamics of an Industry Network (1997) (88)
- Is Europe Evolving Toward an Integrated Research Area? (2013) (80)
- The size variance relationship of business firm growth rates (2008) (78)
- A Multi-Level Geographical Study of Italian Political Elections from Twitter Data (2014) (76)
- On Firm Growth in Networks (2002) (73)
- Betweenness centrality of fractal and nonfractal scale-free model networks and tests on real networks. (2007) (72)
- Reconstructing a credit network (2013) (69)
- On Size and Growth of Business Firms (2003) (67)
- On Economic Complexity and the Fitness of Nations (2017) (65)
- The Memory of Science: Inflation, Myopia, and the Knowledge Network (2016) (65)
- Public health, innovation and intellectual property rights: report of the Commission on Intellectual Property Rights, Innovation and Public Health (2006) (64)
- Medical Devices: Competitiveness and Impact on Public Health Expenditure (2005) (63)
- THE GROWTH OF BUSINESS FIRMS: FACTS AND THEORY (2007) (62)
- Dynamic competition in pharmaceuticals (2004) (61)
- Statistical Properties of Business Firms Structure and Growth (2004) (55)
- Preferential Attachment and Growth Dynamics in Complex Systems (2006) (54)
- Time, space and social interactions: exit mechanisms for the Covid-19 epidemics (2020) (53)
- Size-dependent standard deviation for growth rates: empirical results and theoretical modeling. (2008) (51)
- Disambiguation of patent inventors and assignees using high-resolution geolocation data (2015) (49)
- The changing boundaries of system companies (1996) (48)
- Dynamic competition in pharmaceuticals. Patent expiry, generic penetration, and industry structure. (2007) (47)
- Methods to account for citation inflation in research evaluation (2019) (44)
- The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis (2002) (43)
- Innovation and competitiveness in European biotechnology (2002) (43)
- Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D (2012) (39)
- Quantifying the negative impact of brain drain on the integration of European science (2017) (37)
- After the lockdown: simulating mobility, public health and economic recovery scenarios (2020) (37)
- Technological Regimes and the Growth of Networks: An Empirical Analysis (2007) (36)
- Scale-free models for the structure of business firm networks. (2010) (35)
- The endless frontier? The recent increase of R&D productivity in pharmaceuticals (2020) (34)
- The Nature and the Extent of the Market for Technology in Biopharmaceuticals (2004) (34)
- Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement (2000) (31)
- Patent disclosure and R&D competition in pharmaceuticals (2008) (28)
- Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market (2019) (26)
- Market structure and drug innovation. (2004) (26)
- A generalized preferential attachment model for business firms growth rates (2006) (23)
- Commodity prices co-movements and financial stability: A multidimensional visibility nexus with climate conditions (2021) (22)
- A generalized preferential attachment model for business firms growth rates (2006) (21)
- Intellectual property, technological regimes and market dynamics (2005) (20)
- Global Ownership and Corporate Control Networks (2017) (20)
- Network communities within and across borders (2013) (20)
- Technological regimes and the evolution of networks of innovators. Lessons from biotechnology and pharmaceuticals (2003) (17)
- Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences (2007) (17)
- Nature of innovation and technology management in system companies (1999) (17)
- Communities and regularities in the behavior of investment fund managers (2019) (16)
- Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry (1999) (16)
- Economic evaluation of HIV treatments: the I.CO.N.A. cohort study. (2004) (16)
- Innovation and Industrial Leadership: Lessons from Pharmaceuticals (2007) (16)
- The productivity crisis in pharmaceutical R & (2011) (15)
- A behavioral approach to instability pathways in financial markets (2020) (14)
- Object-oriented influence diagram for cost–effectiveness analysis of influenza vaccination in the Italian elderly population (2006) (12)
- Learning from successes and failures in pharmaceutical R&D (2016) (12)
- Weighted networks as randomly reinforced urn processes. (2013) (11)
- Financial earthquakes: SARS-CoV-2 news shock propagation in stock and sovereign bond markets (2021) (11)
- Socioeconomic differences and persistent segregation of Italian territories during COVID-19 pandemic (2021) (10)
- Spatial heterogeneity in non-parametric efficiency: An application to Italian hospitals. (2019) (10)
- Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals (2000) (10)
- Politiche di liberalizzazione e concorrenza in Italia (2007) (10)
- Investment communities: Behavioral attitudes and economic dynamics (2018) (10)
- Financial crises: Uncovering self-organized patterns and predicting stock markets instability (2021) (10)
- Better to stay apart: asset commonality, bipartite network centrality, and investment strategies (2018) (9)
- The Accounting Network: How Financial Institutions React to Systemic Crisis (2016) (9)
- Climatic Change and Financial Stability: Natural Disaster Impacts on Global Stock Markets (2021) (9)
- The Rise and Fall of Business Firms: A Stochastic Framework on Innovation, Creative Destruction and Growth (2020) (8)
- The Value of Failure in Pharmaceutical R&D (2012) (8)
- Effects of mobility restrictions during COVID19 in Italy (2021) (8)
- Banks’ business strategies on the edge of distress (2019) (8)
- Global competitiveness in pharmaceuticals. A European perspective. November 2000 (2000) (8)
- Variety and Irreversibility in Scientific and Technological Systems: the Evolution of an Industry Network (2001) (8)
- Border sensitive centrality in global patent citation networks (2014) (8)
- The Rise and Fall of Business Firms (2020) (8)
- Real Options and Incremental Search in Pharmaceutical R&D Project Portfolio Management (2016) (7)
- Technological Regimes and the Growth of Networks (2001) (7)
- Between Geography and Demography: Key Interdependencies and Exit Mechanisms for Covid-19 (2020) (7)
- La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale (2007) (6)
- Technological Competencies in Networks of Innovators (2004) (6)
- Long-term correlations in short, non-stationary time series: An application to international R&D collaborations (2019) (5)
- Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata (2004) (5)
- Innovation and Corporate Dynamics: A Theoretical Framework (2011) (5)
- Systemic Importance of Financial Institutions: Regulations, Research, Open Issues, Proposals (2014) (5)
- Systemic Risk and Banking Regulation: Some Facts on the New Regulatory Framework (2015) (5)
- Bayesian cost-effectiveness analysis based on the persistence with antihypertensive treatment (2003) (4)
- Introduzione. Liberalizzazioni e concorrenza in Italia (2007) (4)
- Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria (2004) (4)
- Access to Medicines and European Market Integration (2016) (4)
- Market instability and the size-variance relationship (2021) (4)
- Nuove politiche per l'innovazione nel settore delle scienze della vita (2009) (4)
- The Endless Frontier? The Recent Upsurge of R&D Productivity in Pharmaceuticals (2019) (4)
- The Value of Failures in Pharmaceutical R&D (2012) (4)
- Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011 (2011) (4)
- A Comparison of Game-Theoretic Models for Parallel Trade (2018) (3)
- Modelli e strategie di marketing (2005) (3)
- Evolution of Controllability in Interbank (2013) (3)
- Intragenerational redistribution in a funded pension system (2018) (3)
- A Generalized Preferential Attachment Model fo r Business Firms Growth Rates: I. Empirical Evidence (2006) (3)
- The network origins of Schumpeterian innovation (2021) (3)
- Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions (2017) (3)
- Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030 (2011) (3)
- Il Costo Sociale della Malattia di Alzheimer (1998) (3)
- Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale (2004) (3)
- Transition drivers and crisis signaling in stock markets (2018) (2)
- Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato (2005) (2)
- Reform of Welfare System, Scale of functioning of PayGo, and development of modern Unemployment Benefits (2012) (2)
- Patent Value and R&D Competition (2008) (2)
- La spesa sanitaria delle Regioni in Italia - Saniregio2017 (2014) (2)
- La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio (2009) (2)
- The economic impact of structural and Cohesion Funds across sectors: Immediate, medium-to-long term effects and spillovers (2022) (2)
- Il ruolo dell’università nei processi di constituency-building per l’innovazione industriale e territoriale: riflessioni sull’esperienza italiana (2001) (2)
- On Economic Complexity and the Fitness of Nations (2017) (2)
- On Innovation, Instability, and Growth. A Review and an Interpretative Framework (2014) (2)
- Resilience and Digital Disruption (2021) (2)
- La Sostenibilità dei Sistemi Sanitari Regionali (2012) (2)
- I Farmaci Oncologici in Italia: innovazione e sostenibilità economica (2012) (2)
- Market Structure, Sunk Costs and Entry in Pharmaceutical R&D (2013) (2)
- In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale (2004) (2)
- I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini (2009) (2)
- La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato (2007) (2)
- The Evolution of Complex Networks: A New Framework (2012) (2)
- I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età (2010) (1)
- Peer-Group Detection of Banks and Resilience to Distress (2016) (1)
- The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data (2017) (1)
- PMS42 HEALTH ECONOMIC EVALUATION OF THE TREATMENT OF OSTEOPOROSIS IN FIVE ITALIAN REGIONS (2009) (1)
- Welfare and research and development incentive effects of uniform and differential pricing schemes (2021) (1)
- Border Sensitive Centralities in Patent Citation Networks Using Asymmetric Random Walks (2013) (1)
- The Sustainability of European Health Care Systems: Beyond Income and Ageing. WP Series University of Verona Department of Economics (ISSN 2036-4679) (2008) (1)
- Structure of Business Firm Networks and Scale-Free Models (2008) (1)
- Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry (2003) (1)
- Patent Disambiguation Data (2017) (1)
- Persistency and Uncertainty Across the Academic Career (2012) (1)
- Europe and the United States: The Power of Networks. Lessons from Technology Transfer (2002) (1)
- The multipillar system for health care financing: Thirteen good reasons for open capitalisation funds covering both pension and health care provisions (2011) (1)
- Small Firms And Technological Change In Markets for Technology. The Pharmaceutical Industry After The Revolution In Molecular Biology (2000) (1)
- Labor Supply and Capital Accumulation in an Aging Economy: When Beveridge Meets Bismarck (2015) (1)
- A generalized preferential attachment model for complex systems (2005) (1)
- Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data (2016) (1)
- (a cura di) Politiche di liberalizzazione e concorrenza in Italia : proposte di riforma e linee di intervento settoriali (2007) (1)
- La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica (2006) (1)
- Ascesa e declino dei tradizionali driver dello sviluppo: nuovi scenari futuri (2015) (1)
- Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine (2006) (1)
- Federalismo e riparto del Fsn-2011: Much Ado About Nothing? (2011) (1)
- Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo (2014) (1)
- Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale (2008) (1)
- Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano (2004) (1)
- I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale (2010) (1)
- Labor Supply Distortion and Capital Accumulation when Public Pension Systems Differ in an Aging Economy (2015) (0)
- The productivity crisis in pharmaceutical R&D. WP Series University of Verona Department of Economics (ISSN 2036-4679) (2010) (0)
- Health Services in an Open Transatlantic Market: A European Perspective (2007) (0)
- Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy (2013) (0)
- Innovation and the Growth of Business Firms A Stochastic Framework (2020) (0)
- PIN29 THE ECONOMIC EVALUATION OF INFLUENZA VACCINATION IN THE ELDERLY POPULATION: A MODEL BASED ON BAYESIAN NETWORKS (2004) (0)
- Health Expenditure in Italy: A Comprehensive Intergovernmental Model (2016) (0)
- Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data (2016) (0)
- Patent Value and R&D Competition in Pharmaceuticals (2007) (0)
- Knowledge Accumulation and Industry Evolution: Growth and diversification patterns of the worldwide pharmaceutical industry (2006) (0)
- Temporary Displacement from Metropolitan Areas in Italy during COVID-19 (2020) (0)
- Research and Development (R&D) Alliances (2016) (0)
- Participation in Global Supply Chains and the Offshorability of Italian Jobs (2021) (0)
- a new approach by Trade Repositories data (2015) (0)
- Better to stay apart: asset commonality, bipartite network centrality, and investment strategies (2019) (0)
- A Public–Private Insurance Model for Disaster Risk Management: An Application to Italy (2022) (0)
- Connected from the outside: The role of U.S. regions in promoting the integration of the European research system (2020) (0)
- Time, Space and Demography: Key Interdependencies and Exit Mechanisms for Covid-19 (2020) (0)
- Welfare effects of uniform and differential pricing schemes: an analysis through quadratic programming (2016) (0)
- La Spesa Sanitaria Delle Regioni in Italia - SaniRegio2015 (Health Expenditure of the Regions in Italy - SaniRegio2015) (2015) (0)
- THE DYNAMICS OF GROWTH AND DIVERSIFICATION OF THE LARGE PHARMACEUTICAL COMPANIES (2005) (0)
- PCV28 PERSISTENCE WITH ANTIHYPERTENSIVE DRUG TREATMENT:AN EVALUATION BASED ON A BAYESIAN COST-EFFECTIVENESS APPROACH (2002) (0)
- R&D Alliences (2013) (0)
- A behavioral approach to instability pathways in financial markets (2020) (0)
- Network communities within and across (2014) (0)
- Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico (2007) (0)
- La regolamentazione delle farmacie in Italia (2010) (0)
- Sistemi sanitari regionali alla sfida del federalismo: una proposta per il finanziamento federalista della sanità (2011) (0)
- Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte (2019) (0)
- Corte di giustizia, età di pensionamento di vecchiaia per le donne e riforma delle pensioni e del welfare in Italia (2009) (0)
- Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione (2005) (0)
- Sicurezza, innovazione e crescita (2004) (0)
- Come velocizzare il passaggio al sistema di calcolo contributivo delle pensioni? Una proposta operativa per rafforzare l'aggancio alla vita attesa (2010) (0)
- Patent Value and R&D Competition. WP Series University of Verona Department of Economics (ISSN 2036-4679) (2008) (0)
- The Way Ahead Towards Advanced Automation: Policy Implication for Core Italian Manufacturing Regions (2021) (0)
- Metodi di analisi e valutazione di servizi logistici in outsourcing (1997) (0)
- Requisiti anagrafici di accesso alle pensioni differenziati tra pilastro pubblico e pilastro privato, per riformare il" welfare system" rispettando le scelte individuali (2009) (0)
- Confronto internazionale dei prezzi dei farmaci OTC - Per apprezzare i vantaggi della liberalizzazione della vendita (2006) (0)
- Do We Learn From Errors? The Economic Impact of Differentiated Policy Restrictions in Italy (2023) (0)
- Che cosa spiega la variabilità regionale (2008) (0)
- Management dell'Innovazione (1999) (0)
- L'integrazione pubblico-privato in sanità e assistenza alla persona (2010) (0)
- Nuove Imprese, Concorrenza e Produttività (2005) (0)
- Introduzione. Liberalizzazioni e concorrenza in Italia [Introduction. Liberalisation and competition in Italy] (2007) (0)
- Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM (2011) (0)
- La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di datore di lavoro (2006) (0)
- Introduction (2021) (0)
- I livelli essenziali di assistenza, la regolazione e la riforma multipilastro (2008) (0)
- Spesa sanitaria, Demografia, Istituzioni (2007) (0)
- A Public-Private Insurance Model for Natural Risk Management: an Application to Seismic and Flood Risks on Residential Buildings in Italy (2020) (0)
- Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo (2008) (0)
- Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura (1998) (0)
- Testing Our Predictions (2020) (0)
- R&D, Within and Between Patent Competition in the Pharmaceutical Industry (2013) (0)
- Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali (2009) (0)
- Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica (2007) (0)
- 1 Intellectual Property , Technological Regimes and Market Dynamics (2006) (0)
- Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica (2003) (0)
- La distribuzione dei farmaci Tra progetti di riforma e incertezze (2011) (0)
- Percorsi evolutivi ed innovativi della funziona logistica nelle imprese industriali (1995) (0)
- Access to Medicines and European Market (2016) (0)
- Un'analisi cross-country (2004) (0)
- Networks Dynamics in the Pharmaceutical Industry (1999) (0)
- La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche (2008) (0)
- Il sistema pensionistico: quale riforma? (2008) (0)
- Technological Regimes and the Growth of Networks Draft (2001) (0)
- La sanità in Italia. Federalismo, regolazione dei mercati, sostenibilità delle finanze pubbliche (2008) (0)
- Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN (2005) (0)
- Il sistema di istruzione italiano: un confronto internazionale (2006) (0)
- A proposal for within-cohort redistribution in a funded pension system (2016) (0)
- Market Structure, Sunk Costs and Scope Economies in Pharmaceutical R&D (2010) (0)
- Regolazione di prezzo, innovazione e ciclo di vita dei prodotti: per una riforma del sistema di pricing nel settore farmaceutico tra Stato, industria e cittadini (2008) (0)
- Co-evolution of Organizational Forms and Technology (1999) (0)
- Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione (2004) (0)
- Indicazioni per la governance della spesa farmaceutica (2008) (0)
- Global Welfare Effects of a Uniform Pricing Parallel Trade-Preventing Strategy: An Analysis Through Quadratic and Maximin Programming (2015) (0)
- LA SPESA SANITARIA DELLE REGIONI (2015) (0)
- Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato (2005) (0)
- Shifts in the ways markets and regulatory forces interact have brought changes to drug innovation in the United States and elsewhere. (2004) (0)
- I numeri del federalismo: una simulazione per la sanità (2010) (0)
- A Game-Theoretic Approach to Parallel Trade Through the Price of Anarchy (2015) (0)
- Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale (2008) (0)
- Il settore farmaceutico tra barriere alla concorrenza e regolazione sul lato del consumo (2007) (0)
- Digital Manufacturing and the Transformation of the Automotive Industry (2021) (0)
- La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro (2012) (0)
- The Financial Sustainability of Italian Regional Health Care Systems (2012) (0)
- Welfare and research and development incentive effects of uniform and differential pricing schemes (2021) (0)
- I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009 (2010) (0)
- Digital Technologies and Industrial Transformations (2021) (0)
- Learning from successes and failures in pharmaceutical R&D (2016) (0)
- The price of pharmaceutical products in Italy. On some recent trends (2014) (0)
- The Nature and the Extent of Markets for Technology (2001) (0)
- La Sostenibilità dei Sistemi Sanitari Regionali [The Financial Sustainability of Italian Regional Health Care Systems] (2012) (0)
- Innovation and competition in the pharmaceutical industry (2014) (0)
- "Life Sciences" in Toscana. La Ricerca è innovativa e competitiva se Università e imprese lavorano in rete (2006) (0)
- Communities of Experts: Uncovering Commonalities in the Behavior of Investment Managers (2019) (0)
- The endless frontier? The recent increase of R&D productivity in pharmaceuticals (2020) (0)
- Banks’ business strategies on the edge of distress (2019) (0)
- Demography, sustainability and growth. Notes on the sustainability of health and pension systems in Europe (2014) (0)
This paper list is powered by the following services:
Other Resources About Fabio Pammolli
What Schools Are Affiliated With Fabio Pammolli?
Fabio Pammolli is affiliated with the following schools:
